Functional MR Unit, Policlinico S. Orsola - Malpighi, via Massarenti 9, 40138 Bologna, Italy; Department of Biomedical and NeuroMotor Sciences, University of Bologna, via Ugo Foscolo 7, 40123 Bologna, Italy.
Department of Biomedical and NeuroMotor Sciences, University of Bologna, via Ugo Foscolo 7, 40123 Bologna, Italy.
Neuroimage Clin. 2016 May 3;11:678-685. doi: 10.1016/j.nicl.2016.04.012. eCollection 2016.
Myotonic dystrophy type 1 (DM1) represents a multisystemic disorder in which diffuse brain white and gray matter alterations related to clinical and genetic features have been described. We aimed to evaluate in the brain of adult patients with DM1 (i) white and gray matter differences, including cortical-subcortical gray matter volume and cortical thickness and (ii) their correlation with clinical disability, global neuropsychological performance and triplet expansion.
We included 24 adult genetically-confirmed DM1 patients (14 males; age: 38.5 ± 11.8 years) and 25 age- and sex-matched healthy controls (14 males; age: 38.5 ± 11.3 years) who underwent an identical brain MR protocol including high-resolution 3D T1-weighted, axial T2 FLAIR and DTI sequences. All patients underwent an extensive clinical and neuropsychological evaluation. Voxel-wise analyses of white matter, performed by using Tract Based Spatial Statistics, and of gray matter, with Voxel-based Morphometry and Cortical Thickness, were carried out in order to test for differences between patients with DM1 and healthy controls (p < 0.05, corrected). The correlation between MRI measures and clinical-genetic features was also assessed.
Patients with DM1 showed widespread abnormalities of all DTI parameters in the white matter, which were associated with reduced gray matter volume in all brain lobes and thinning in parieto-temporo-occipital cortices, albeit with less extensive cortical alterations when congenital cases were removed from the analyses. White matter alterations correlated with clinical disability, global cognitive performance and triplet expansions.
In patients with DM1, the combined smaller overall gray matter volume and white matter alterations seem to be the main morpho-structural substrates of CNS involvement in this condition. The correlation of white matter differences with both clinical and genetic findings lends support to this notion.
1 型肌强直性营养不良(DM1)是一种多系统疾病,已描述其与临床和遗传特征相关的弥散性脑白质和灰质改变。我们旨在评估成年 DM1 患者的脑内情况:(i)白质和灰质差异,包括皮质下灰质体积和皮质厚度;(ii)这些差异与临床残疾、整体神经心理学表现和三核苷酸扩展的相关性。
我们纳入了 24 名成年经基因确诊的 DM1 患者(14 名男性;年龄:38.5±11.8 岁)和 25 名年龄和性别匹配的健康对照者(14 名男性;年龄:38.5±11.3 岁),他们接受了相同的脑磁共振成像(MRI)方案,包括高分辨率 3D T1 加权、轴位 T2 FLAIR 和弥散张量成像(DTI)序列。所有患者均接受了广泛的临床和神经心理学评估。通过基于体素的空间统计学(Voxel Based Spatial Statistics)对白质进行体素分析,通过基于体素的形态计量学(Voxel Based Morphometry)和皮质厚度对白质进行分析,以测试 DM1 患者与健康对照者之间的差异(p<0.05,校正)。还评估了 MRI 测量值与临床-遗传特征的相关性。
DM1 患者的白质所有 DTI 参数均存在广泛异常,这些异常与所有脑叶的灰质体积减少以及顶颞枕皮质变薄相关,不过,如果将先天性病例从分析中去除,则皮质改变的范围较小。白质改变与临床残疾、整体认知表现和三核苷酸扩展相关。
在 DM1 患者中,整体灰质体积较小和白质改变似乎是 CNS 受累的主要形态结构基础。白质差异与临床和遗传发现的相关性支持了这一观点。